MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202527114598 A) filed by Wigen Biomedicine Technology Shanghai Co. , Ltd. on November 20, 2025, for Selective Inhibitor And Use Thereof.
Inventors include Xu, Ruihua; Wang, Feng; Xie, Yuli; Liu, Wenzhong; and Qian, Lihui.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: Disclosed in the present invention are an HDAC1/2 selective inhibitor and the use thereof. Specifically, the present invention relates to a compound as represented by general formula (1) and a preparation method therefor, and the use of the compound as represented by general formula (1) and each isomer, each crystal form, a pharmaceutically acceptable salt, a hydrate or a solvate thereof as the HDAC1/2 selective inhibitor in the preparation of an anti-tumor drug.
Disclaimer: Curated by HT Syndication.
